Raymond James & Associates’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-21,538
| Closed | -$669K | – | 3995 |
|
|
2022
Q2 | $669K | Buy |
21,538
+329
| +2% | +$11.2K | ﹤0.01% | 2723 |
|
|
2022
Q1 | $871K | Buy |
21,209
+4,258
| +25% | +$188K | ﹤0.01% | 2699 |
|
|
2021
Q4 | $737K | Sell |
16,951
-2,036
| -11% | -$92.1K | ﹤0.01% | 2821 |
|
|
2021
Q3 | $951K | Buy |
18,987
+1,331
| +8% | +$80.6K | ﹤0.01% | 2616 |
|
|
2021
Q2 | $1.11M | Sell |
17,656
-13,641
| -44% | -$876K | ﹤0.01% | 2516 |
|
|
2021
Q1 | $2.91M | Buy |
31,297
+11,081
| +55% | +$1.13M | ﹤0.01% | 1777 |
|
|
2020
Q4 | $1.81M | Buy |
20,216
+980
| +5% | +$89.9K | ﹤0.01% | 1945 |
|
|
2020
Q3 | $1.99M | Buy |
19,236
+2,247
| +13% | +$242K | ﹤0.01% | 1776 |
|
|
2020
Q2 | $1.34M | Buy |
16,989
+4,654
| +38% | +$347K | ﹤0.01% | 1962 |
|
|
2020
Q1 | $714K | Buy |
+12,335
| New | +$711K | ﹤0.01% | 2192 |
|
|
2019
Q4 | – | Sell |
-4,718
| Closed | -$247K | – | 3682 |
|
|
2019
Q3 | $247K | Buy |
+4,718
| New | +$220K | ﹤0.01% | 3126 |
|
|
2019
Q2 | – | Sell |
-9,081
| Closed | -$459K | – | 3672 |
|
|
2019
Q1 | $459K | Sell |
9,081
-2,074
| -19% | -$122K | ﹤0.01% | 2715 |
|
|
2018
Q4 | $661K | Buy |
11,155
+416
| +4% | +$26.8K | ﹤0.01% | 2351 |
|
|
2018
Q3 | $707K | Buy |
10,739
+317
| +3% | +$18.5K | ﹤0.01% | 2466 |
|
|
2018
Q2 | $526K | Sell |
10,422
-374
| -3% | -$19.5K | ﹤0.01% | 2647 |
|
|
2018
Q1 | $568K | Buy |
10,796
+3,136
| +41% | +$156K | ﹤0.01% | 2484 |
|
|
2017
Q4 | $356K | Hold |
7,660
| – | – | ﹤0.01% | 2741 |
|
|
2017
Q3 | $310K | Sell |
7,660
-414
| -5% | -$15K | ﹤0.01% | 2771 |
|
|
2017
Q2 | $274K | Buy |
8,074
+915
| +13% | +$28.2K | ﹤0.01% | 2778 |
|
|
2017
Q1 | $208K | Buy |
7,159
+135
| +2% | +$4.11K | ﹤0.01% | 2912 |
|
|
2016
Q4 | $231K | Buy |
7,024
+424
| +6% | +$12.7K | ﹤0.01% | 2806 |
|
|
2016
Q3 | $208K | Sell |
6,600
-1,856
| -22% | -$53.9K | ﹤0.01% | 2828 |
|
|
2016
Q2 | $238K | Buy |
8,456
+36
| +0.4% | +$1.41K | ﹤0.01% | 2547 |
|
|
2016
Q1 | $306K | Buy |
+8,420
| New | +$297K | ﹤0.01% | 2313 |
|
Other funds holding EBS
